Table 2. Per group evaluation of patient demography, VAS and WOMAC scores at baseline and follow-up visits.
| Group I | Group II | Group III | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SD | /n - % | Median | Mean ±SD | / n - % | Median | Mean ±SD | / n - % | Median | ||
| Age | 44.6 ± 7.5 | 47 | 43.3 ± 7.8 | 43 | 38.9 ± 8.6 | 38 | ||||
| Gender | Female | 12 | 80.0% | 17 | 70.8% | 12 | 75.0% | |||
| Male | 3 | 20.0% | 7 | 29.2% | 4 | 25.0% | ||||
| VAS Score | ||||||||||
| Baseline | 8.2 ± 0.4 | 8 | 8.3 ± 0.5 | 8 | 8.2 ± 0.4 | 8 | ||||
| 1st month | 3.8* ± 2.2 | 2 | 2.4* ± 0.5 | 2 | 2.9* ± 1.3 | 2 | ||||
| 3rd month | 3.7* ± 2.3 | 2 | 2.4* ± 0.9 | 2 | 2.8* ± 1.4 | 2 | ||||
| 6th month | 3.5* ± 2 | 2 | 2.4* ± 0.9 | 2 | 2.6* ± 1 | 2 | ||||
| WOMAC Score | ||||||||||
| Baseline | 96.1 ± 0.4 | 96 | 94 ± 8.1 | 96 | 96 ± 0 | 96 | ||||
| 1st month | 49.6* ± 30.7 | 48 | 40.4* ± 13.8 | 37 | 46.6* ± 30.9 | 24.5 | ||||
| 3rd month | 51.5* ± 30.8 | 52 | 37.7* ± 14.1 | 37 | 41.9* ± 32 | 24 | ||||
| 6th month | 26.3* ± 1.8 | 26 | 24.6* ± 0.9 | 24 | 44.6* ± 28.1 | 29 | ||||
*Significant when compared to baseline (Wilcoxon test, p<0.05), SD: standard deviation; VAS: Visual analogue scale; WOMAC: Western Ontario and McMaster Universities Arthritis Index